1. INTRODUCTION

Please read this Privacy Policy in order to have permission to use our services.

2. DATA COLLECTED.

DATA STORAGE LOCATION

We operate web servers hosted in Germany. Our hosting provider Hetzner Online GmbH adheres to the EU/US “Privacy Shield,” ensuring that your data is stored securely and GDPR-compliant. For more information about Hetzner Online GmbH’s privacy policy, see here:
Hetzner Data Privacy Policy
.

REGISTRATION DATE

If you register on our Web site, we store your chosen username and e-mail address and any additional personal information added to your user profile. You can see, change, or delete your personal information at any time (with the exception of changing your username). Website administrators can also see and edit this information.

COMMENTS

When you leave comments on the Web site, we collect the data shown in the comment form, as well as your IP address and browser user agent string to facilitate spam detection.

CONTACT FORM

Information submitted via the contact form on our site is sent to our corporate e-mail, hosted by Siteground. Siteground joins EU

These mailings are retained for customer service purposes only and are never used for marketing purposes or shared with third parties.

GOOGLE ANALYTICS

We use Google Analytics on our site for anonymous reporting of site usage. Therefore, no personalized data is stored. If you would like to disable the tracking of your behavior on our website by Google Analytics, please use this link:
Google Analytics Opt-out
.

CASES FOR USING THE PERSONAL DATA

We use your personal information in the following cases:

Verification/identification of the user while using the website;
Providing technical assistance;
Sending updates to our users with important information to inform about news/changes;
Monitoring account activity in order to prevent fraudulent transactions and ensure the security of our customers’ personal information;
Customize the website to make your experience more personal and engaging;
Ensure smooth overall performance and administrative functions.

3. EMBEDDED CONTENT

Pages on this site may include embedded content, such as YouTube videos, for example. Embedded content from other websites behaves exactly as if you visited the other website. These Web sites may collect data about you, use cookies, embed additional third-party tracking, and track your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that Web site. Below you can find a list of the services we use: FACEBOOK The Facebook page plug-in is used to display our Facebook history on our site. Facebook has its own cookie and privacy policies over which we have no control. There is no cookie installation by Facebook and your IP is not sent to a Facebook server until you consent. See their privacy policy here: Facebook Privacy Policy. TWITTER We use the Twitter API to display the history of our tweets on our site. Twitter has its own cookie and privacy policies over which we have no control. Your IP is not sent to a Twitter server until you consent. See their privacy policy here: Twitter Privacy Policy . YOUTUBE We use YouTube videos embedded on our site. YouTube has its own cookie and privacy policies over which we have no control. There is no installation of cookies by YouTube and your IP is not sent to a YouTube server until you consent. See their privacy policy here: YouTube Privacy Policy.

4. COOKIES

This site uses cookies, small text files that are placed on your computer to help the site provide a better user experience. In general, cookies are used to store user preferences, store information for things like shopping carts, and provide anonymous tracking data to third-party applications such as Google Analytics. Cookies generally exist to improve your browsing experience. However, you may prefer to disable cookies on this site and others. The most effective way to do this is to disable cookies in your browser. We suggest you consult the help section of your browser. COOKIES REQUIRED (ALL SITE VISITORS) cfduid: is used for our CloudFlare CDN to identify individual clients behind a shared IP address and apply security settings on a per-client basis. See more information about privacy here: CloudFlare Privacy Policy. PHPSESSID: to identify your unique session on the website. COOKIES REQUIRED (ADDITIONAL FOR CUSTOMERS WHO HAVE LOGINED) wp-auth: Used by WordPress to authenticate visitors who have logged in, password authentication and user verification. wordpress_logged_in_{hash}: used by WordPress to authenticate visitors who have logged in, password authentication and user verification. wordpress_test_cookie Used by WordPress to ensure cookies work properly. wp-settings-[UID]: WordPress sets some cookies from wp-settings-[UID]. The number at the end is your individual user ID from the user database table. This is used to customize the display of the administration interface and possibly even the main interface of the site. wp-settings-[UID]:WordPress also sets some cookies from wp-settings-{time}-[UID]. The number at the end is your individual user ID from the user database table. This is used to customize the display of the administration interface and possibly even the main interface of the site.

5. WHO HAS ACCESS TO YOUR DATA

If you are not a registered customer for our site, there is no personal information we can store or display about you. If you are a customer with a registered account, the following can access your personal information: Our system administrators. Our supporters when (to provide support) they need to obtain customer account information and access.

6. THIRD PARTY ACCESS TO YOUR DATA

We do not share your data with third parties in a way that reveals any of your personal information such as e-mail, name, etc.

7. HOW LONG WE RETAIN YOUR DATA

When you submit a support ticket or comment, the related metadata is retained until (if) you tell us to remove it. We use this data so that we can automatically recognize and approve your comments instead of withholding them for moderation. If you register on our Web site, we also store the personal information you provide in your user profile. You can see, change, or delete your personal information at any time (with the exception of changing your username). Website administrators can also view and edit this information.

8. SECURITY MEASURES

We use the SSL/HTTPS protocol throughout our site. This encrypts our user communications with the servers so that personally identifiable information is not captured/routed by third parties without authorization.

In the event of a data breach, system administrators will immediately take all necessary measures to ensure the integrity of the system, contact the affected users, and attempt to reset passwords if necessary.

9. YOUR DATA RIGHTS

GENERAL RIGHTS.

GENERAL RIGHTS If you have a registered account on this website or have left comments, you can request an exported file of the personal data we keep, including any additional data you have provided to us. You can also request that we delete any personal data we have stored. This does not include data that we are obliged to keep for administrative, legal or security purposes. In short, we cannot delete data vital to being an active customer (such as basic account information like an e-mail address). If you wish to have all your data deleted, we will no longer be able to offer you any support or other product-related services. GDPR RIGHTS Your privacy is of paramount importance to us. Moving forward with GDPR we aim to support the GDPR standard. AxiomThemes allows residents of the European Union to use its Service. Therefore, it is the intention of AxiomThemes to comply with the European General Data Protection Regulation. For more details, see here: EU GDPR Information Portal.

10. THIRD PARTY WEBSITES

All social media sharing links, displayed as text links or social media icons, do not link you to any of the associated third parties unless you explicitly click on them. Please be aware that this Privacy Policy and any other policies in effect, as well as any amendments thereto, do not create enforceable rights from third parties or require disclosure of personal information about members of the Service or Site. Medi Jeunesse assumes no responsibility for the information collected or used by any third-party advertiser or Web site. Please review the privacy policy and terms of service for each site visited through third-party links.

11. RELEASE OF YOUR DATA FOR LEGAL PURPOSES

Sometimes it may be necessary or desirable for Medi Jeunesse, for legal purposes, to release your information in response to a request from a government agency or private litigation. You agree that we may disclose your information to third parties where we believe, in good faith, that it is desirable to do so for the purpose of a civil action, criminal investigation, or other legal matter. In the event that we receive a subpoena that affects your privacy, we may choose to notify you to give you an opportunity to file a motion to quash the subpoena, or we may attempt to quash it ourselves, but we are not obligated to do so. We may also proactively report you and release your information to third parties where we believe it is prudent to do so for legal reasons, such as our belief that you have engaged in fraudulent activity. You release us from any harm that may arise from or be related to the release of your information to a law enforcement or private party request. Any transfer of personal data for legal purposes will be made only in accordance with the laws of the country in which you reside.

12. AMENDMENTS

We may change this Privacy Policy from time to time. When we change this Privacy Policy, we will update this page accordingly and ask you to accept the changes so that you can continue to use our services.

13. Informed Consent Golden Lipo

MINIMALLY INVASIVE TREATMENT FOR EMULSIFICATION OF LOCALIZED SUBCUTANEOUS FAT USING OPTICAL FBRA LASER EQUIPMENT

Dear patient,

Prior to Golden Lipo ( subcutaneous fiber laser lipoemulsion) treatment, your current health status and previous illnesses will be assessed, and as needed, all necessary blood and diagnostic investigations will be performed to verify that a safe and effective result can be achieved. To prevent infection, your doctor may prescribe an oral antibiotic for you to take on your doctor’s advice in the days before and after treatment. On the day of the Golden Lipo treatment, the areas to be treated will be determined and drawn and photographed.

HOW DOES GOLDEN LIPO TREATMENT WORK ?

Golden Lipo treatment makes use of a Diode Laser equipment with which thermal energy is emitted that is programmed to melt and emulsify fat cells. The transmission within the areas to be treated of this energy is through an optical fiber of thickness ranging from 0.6 to 1 millimeter. Fiber insertion is done after injecting the entire treatment area with 0.5 to 1 liter of Klein’s solution consisting of 1 liter of 0.9 Nacl saline , 20 to 30 ml of 2% lidocaine, adrenaline 1 vial of 1 ml, sodium bicarbonate 4 vials of 2 ml. Such solution will have not only the role of emulsifying liquid but also the role of sedation.
Once the treatment area has been drawn and photographed, it is disinfected with Betadine and Klein’s solution is inoculated. After the injective phase is finished, the optical fiber is introduced and the laser energy is emitted by moving the optical fiber with forward and backward displacements. The release of droplets of adipose fluid will be a sign that emulsification has taken place and will cause the treatment to proceed to neighboring areas. At the end of treatment, the entire area will be cooled and medicated with Betadine, Fucidin antibiotic ointment, sterile compresses and gauze, and compression bandage. It is mandatory to wear a sheath
compressive elastic for 2 weeks to prevent post-treatment swelling and/or hematoma. The total duration of treatment ranges from 90 to 120 minutes. Your doctor may advise you to limit your activities for a few days after your Golden Lipo treatment and indicate when you can resume them regularly.

POSSIBLE COMPLICATIONS AND SIDE EFFECTS

Some side effects may occur at and around the treated areas, including : Fading ( general whitening ), hematomas, lymphedema (i.e., swelling, water retention, edema), hematomas (local accumulations of blood), hemosiderosis (hematomas that last longer than normal under the skin due to iron deposits), hyperpigmentation (dark spots on the skin), hypopigmentation (light spots on the skin), indurations (hardening or solidification under the skin), general inflammation and redness, slight bleeding (at areas of optical fiber iontroduction), skin areas of numbness, itching or excessive sensitivity, redness, erythema or rash at areas of optical fiber entry, changes or irregularities in the skin surface, sensation of pain in the treated areas.
As with any medical procedure, risks such as: Abscesses (collection of pus), fluid formation and/or leakage, anetoderma, (skin areas characterized by stagnation or reduced elasticity), bleeding, extravasation of fluid (leakage of fluid into tissues), fibrosis (formation of redundant connective tissues), infection, discomfort/ nausea, numbness/itchiness, scar or keloid formation, seroma formation (formation of clear fluid in tissue cavities), skin necrosis (dead cells on the skin), and/or toxic, allergic, or other reactions that are caused by the device or injection of Klein’s solution.
AFTER TREATMENT

After treatment, a date is set for your post-treatment follow-up appointment, which occurs on average a week apart and will test your overall health and that of the treated areas. A second appointment is scheduled 30 to 60 days later. During the latter, photographs could be taken again to verify the results obtained.
Should you have any problems or need any information or advice, please contact us as soon as possible

PATIENT SIGNATURE

INFORMED CONSENT

THE UNDERSIGNED /a
……………………………………………………………………………………………………………………

Born /to …………………………………………………………….. on ………. / ……… / ………………..

Address
…………………………………………………………………………………………………………………..

I DECLARE TO.
I read the patient information sheet, understood it, and agreed to undergo the Golden Lipo treatment. Treatment takes place on an outpatient basis.

I was listed in detail in an informational interview the dangers and information regarding fiber optic laser lipoemulsion treatment, such as type, content,possibil risks, unwanted effects, and prospects for success.

I am aware that the doctor cannot guarantee the desired results by means of the treatment performed.

I am aware that post-treatment checkups are mandatory and in case of prolonged absence from them absolves the doctor from any responsibility.

I had the opportunity to ask questions that were answered thoroughly

I also received informational materials for subscribers and through the web and was given enough time to reflect.

I answered the questions regarding my past illnesses according to my conscience.

I am aware that prior to processing I may revoke this statement of consent without giving reasons.

Should it be necessary to implement unforeseen changes or an extension of the agreed treatment, I agree with the implementation of the necessary measures.

That for any problems or any further information I should contact DR. GIUSEPPE MANCUSO TEL: 091 6000707

Place …………………………………………………………… Date …………
Patient’s full name…………………………………
Patient’s signature Physician’s signature

14. Medilift Informed Consent Face

ENDOLIFT LASER TREATMENT

GENERAL INFORMATION CONTENT

The patient before undergoing Medilift laser treatment is aware that:

To date, International research conducted on the use of the laser and clinical results indicate that laser therapy is safe while there is no guarantee that laser treatment will completely eliminate the lesion or blemish being treated. In some cases, laser treatments give only temporary results.

Due to different individual responses, it is not possible a priori to quantify exactly the percentage of improvement in the defect to be corrected, the extent and duration of the result
I accept the possible cosmetic discomforts (redness, edema, burn, purpura, hematoma, ulcer, abrasion, pop-corn effect, etc.) of the post-treatment period of varying duration and the appearance of skin burns of varying degree and kind attributable to variable photobiological results for each patient dependent on the individual responses of the body rather than the Biomedical Techniques and Technologies used.

I am aware that in some cases dark or light spots may remain even for long periods on treated skin due to individual hypersensitivity.

The information about the treatment and possible outcomes that I was given is extensive, truthful, realistic, and complete.

I agree to observe the Medical and Physical Therapies and post-treatment precautions that have been indicated and recommended to me with possible follow-ups knowing that failure to do so may compromise the final result.

I agree to be photographed before, during and after treatment for documentation purposes that the doctor agrees to use only by ensuring absolute anonymity and of which I cannot request copies

In the face of possible complications, and in agreement with the doctor, as of now I give my consent to the treatment

SPECIFIC INFORMATION CONTENT
MEDILIFT with Lasemar 1500 is a new method to create skin tightening and dermal rejuvenation

HOW IT WORKS.
The main feature of the Medilift treatment is the ability to heat soft tissue by bringing to a high temperature the subcutaneous structures with which the Laser probe comes into contact
Such minimally invasive treatment is performed in an outpatient setting with laser fiber optics on the order of microns, thus particularly small.
Following your doctor’s advice, is critical both for the success of the treatment and to avoid complications and risks.

ABSOLUTE CONTRAINDICATIONS
The following should not be subjected to treatment
– pregnant women
– Subjects with continuous skin solutions, abrasions, wounds, localized skin conditions
– subjects with spastic paralysis
– Subjects with ongoing thrombosis and/or thrombophlebitis
– transplanted patients
– subjects undergoing anticoagulant therapy
– subjects with neoplasms

INCREASED RISK OF COMPLICATIONS
– Subjects on antiplatelet therapy (increased risk of bruising and hematoma)
– Diabetic patients (increased risk of infection)
– Patients on chronic corticosteroid treatment (increased risk of burns and discoloration)
– Subjects who use narcotics, especially cannabinoids ( umented photosensitivity resulting in increased risk of local complications)

TREATMENT PROTOCOL

Before lactation
– If the patient has mitral prolapse or other cardiac pathology that increases the risk of endocarditis, he/she should assemure 2 gr of amoxicillin ( e.g. Augmentin)1 hour before the procedure, if allergic to amoxicillin, he/she will take 600 mg of clindamycin )1 hour before the procedure.
– If the patient is being treated with cardioaspirin, he/she will suspend (with the caregiver’s consent) the treatment 4 days before the treatment and resume it the day after the tactation itself.
– He will apply , one hour before the treatment , anesthetic cream (e.g., emla) to the area to be treated.

During treatment
– The treatment will be performed under local anesthesia
– At the end of lactation, moisturizing cream and antibiotic ointment will be applied locally in copious amounts

After treatment
– Will avoid direct exposure to the sun or lamps for at least 15 days. However, when not
indoor environments will apply sunscreen at least 50+ every two hours.
– Will regularly show up for doctor’s scheduled checkups

I, the undersigned

First name ………………………………………………….. Last name ……………………………………………….

states that he/she has read the informed consent protocol attached to this form. The treatment was explained to me in detail by the doctor, and I believe I understood its purposes and limitations.

In particular, I know that:
AFTER TREATMENT – After treatment in most cases there is no pain, although some mild swelling of the face may occur, which is expected to gradually decrease over a few hours

The final result can only be assessed a few months later, and in the weeks following treatment there will be a slow and gradual improvement

The final result does not last indefinitely in time.

The patient should be aware of the importance of strictly following medical advice to
Achieve the desired aesthetic results in the shortest possible time

– AUTHORIZE
–
Dr. Mancuso Giuseppe and his staff to perform Medilift facial treatment on me with 1470nm laser (_Lasemar 1500_).

– I authorize: Dr Mancuso Giuseppe (Physician) and his staff to modify according to science and conscience and according to contingent needs the planned techniques, both during the treatment itself and in the post-treatment period. I agree to undergo the medical and physical therapies that will be prescribed for me in the post-treatment period, being informed that failure to do so may jeopardize the outcome of the treatment. Mi
I agree not to undergo other therapies prescribed by other physicians during the post-treatment period without prior consent from Dr. Mancuso. Since medicine is not an exact science, the percentage of improvement of the defect to be corrected cannot be precisely predicted a priori, and the duration of the result, as well as the quality of the results, depend not only on the techniques employed but even more on the body’s responses. Such complications can be treated, and to this end I consent to undergo appropriate treatment, possibly including surgery.
I agree to be photographed before, during, and after surgery for the purpose of clinical documentation, which the surgeon agrees to use only with absolute assurance of anonymity. It will not be possible to request copies of photos taken in the studio

Patient signature ………………………………………………………………………………………………………………………..

Surgeon’s signature ………………………………………………………………………………………………………………………..

Date

15. Liposhock Informed Consent.

MINIMALLY INVASIVE TREATMENT FOR EMULSIFICATION OF LOCALIZED SUBCUTANEOUS FAT USING FIBER OPTIC LASER EQUIPMENT

Dear patient,

Before Liposhock treatment ( subcutaneous fiber optic laser lipoemulsion) will be performed, your current health status and previous illnesses will be assessed, and as needed, all necessary blood and diagnostic investigations will be performed to verify that a safe and effective result can be achieved. To prevent infection, your doctor may prescribe an oral antibiotic for you to take on your doctor’s advice in the days before and after treatment. On the day of the Golden Lipo treatment, the areas to be treated will be determined and drawn and photographed.

HOW DOES LIPOSHOCK TREATMENT WORK ?

Liposhock treatment makes use of a Diode Laser equipment with which thermal energy is emitted that is programmed to melt and emulsify fat cells. The transmission within the areas to be treated of this energy is through an optical fiber of thickness ranging from 0.6 to 1 millimeter. Fiber insertion is done after injecting the entire treatment area with 0.5 to 1 liter of Klein’s solution consisting of 1 liter of 0.9 Nacl saline , 20 to 30 ml of 2% lidocaine, adrenaline 1 vial of 1 ml, sodium bicarbonate 4 vials of 2 ml. Such solution will have not only the role of emulsifying liquid but also the role of sedation.
Once the treatment area has been drawn and photographed, it is disinfected with Betadine and Klein’s solution is inoculated. After the injective phase is finished, the optical fiber is introduced and the laser energy is emitted by moving the optical fiber with forward and backward displacements. The release of droplets of adipose fluid will be a sign that emulsification has taken place and will cause the treatment to proceed to neighboring areas. At the end of treatment, the entire area will be cooled and medicated with Betadine, Fucidin antibiotic ointment, sterile compresses and gauze, and compression bandage. It is mandatory to wear a sheath
compressive elastic for 2 weeks to prevent post-treatment swelling and/or hematoma. The total duration of treatment ranges from 90 to 120 minutes. Your doctor may advise you to limit your activities for a few days after Liposhock treatment and indicate when you can resume them regularly.

POSSIBLE COMPLICATIONS AND SIDE EFFECTS

PATIENT SIGNATURE

INFORMED CONSENT

THE UNDERSIGNED /a
…………………………………………………………………………………………………………………… Born /to …………………………………………………………….. on ………. / ……… / ………………..
Address
…………………………………………………………………………………………………………………..

I DECLARE TO.
I read the patient information sheet, understood it, and agreed to undergo the Liposhock treatment. Treatment takes place on an outpatient basis.